United States Prophylactic Human Vaccine Market Report & Forecast 2021-2027

Publisher Name :
Date: 12-Oct-2021
No. of pages: 90
Inquire Before Buying

United States Prophylactic Human Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Prophylactic Human Vaccine Market Segment Percentages, By Type, 2020 (%)

- Inactivated Vaccine

- Attenuated Vaccine

- Others

United States Prophylactic Human Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Prophylactic Human Vaccine Market Segment Percentages, By Application, 2020 (%)

- Hospital

- Scientific Research

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Prophylactic Human Vaccine revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Prophylactic Human Vaccine revenues share in United States market, 2020 (%)

Key companies Prophylactic Human Vaccine sales in United States market, 2016-2021 (Estimated), (K Units)

Key companies Prophylactic Human Vaccine sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- GSK

- Biovac

- McKesson Medical

- Merck

- Merial

- Zoetis

- Sanofi

United States Prophylactic Human Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Prophylactic Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Prophylactic Human Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Prophylactic Human Vaccine Overall Market Size
2.1 United States Prophylactic Human Vaccine Market Size: 2021 VS 2027
2.2 United States Prophylactic Human Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Prophylactic Human Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Prophylactic Human Vaccine Players in United States Market
3.2 Top United States Prophylactic Human Vaccine Companies Ranked by Revenue
3.3 United States Prophylactic Human Vaccine Revenue by Companies
3.4 United States Prophylactic Human Vaccine Sales by Companies
3.5 United States Prophylactic Human Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Prophylactic Human Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Prophylactic Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prophylactic Human Vaccine Players in United States Market
3.8.1 List of Tier 1 Prophylactic Human Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Prophylactic Human Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Prophylactic Human Vaccine Market Size Markets, 2021 & 2027
4.1.2 Inactivated Vaccine
4.1.3 Attenuated Vaccine
4.1.4 Others
4.2 By Type - United States Prophylactic Human Vaccine Revenue & Forecasts
4.2.1 By Type - United States Prophylactic Human Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Prophylactic Human Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Prophylactic Human Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Prophylactic Human Vaccine Sales & Forecasts
4.3.1 By Type - United States Prophylactic Human Vaccine Sales, 2016-2021
4.3.2 By Type - United States Prophylactic Human Vaccine Sales, 2022-2027
4.3.3 By Type - United States Prophylactic Human Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Prophylactic Human Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Prophylactic Human Vaccine Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - United States Prophylactic Human Vaccine Revenue & Forecasts
5.2.1 By Application - United States Prophylactic Human Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Prophylactic Human Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Prophylactic Human Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Prophylactic Human Vaccine Sales & Forecasts
5.3.1 By Application - United States Prophylactic Human Vaccine Sales, 2016-2021
5.3.2 By Application - United States Prophylactic Human Vaccine Sales, 2022-2027
5.3.3 By Application - United States Prophylactic Human Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Prophylactic Human Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 GSK Prophylactic Human Vaccine Product Description
6.1.5 GSK Recent Developments
6.2 Biovac
6.2.1 Biovac Corporation Information
6.2.2 Biovac Overview
6.2.3 Biovac Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Biovac Prophylactic Human Vaccine Product Description
6.2.5 Biovac Recent Developments
6.3 McKesson Medical
6.3.1 McKesson Medical Corporation Information
6.3.2 McKesson Medical Overview
6.3.3 McKesson Medical Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 McKesson Medical Prophylactic Human Vaccine Product Description
6.3.5 McKesson Medical Recent Developments
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Overview
6.4.3 Merck Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Merck Prophylactic Human Vaccine Product Description
6.4.5 Merck Recent Developments
6.5 Merial
6.5.1 Merial Corporation Information
6.5.2 Merial Overview
6.5.3 Merial Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Merial Prophylactic Human Vaccine Product Description
6.5.5 Merial Recent Developments
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Overview
6.6.3 Zoetis Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 Zoetis Prophylactic Human Vaccine Product Description
6.6.5 Zoetis Recent Developments
6.7 Sanofi
6.7.1 Sanofi Corporation Information
6.7.2 Sanofi Overview
6.7.3 Sanofi Prophylactic Human Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 Sanofi Prophylactic Human Vaccine Product Description
6.7.5 Sanofi Recent Developments
7 United States Prophylactic Human Vaccine Production Capacity, Analysis
7.1 United States Prophylactic Human Vaccine Production Capacity, 2016-2027
7.2 Prophylactic Human Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Prophylactic Human Vaccine Supply Chain Analysis
9.1 Prophylactic Human Vaccine Industry Value Chain
9.2 Prophylactic Human Vaccine Upstream Market
9.3 Prophylactic Human Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Prophylactic Human Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Prophylactic Human Vaccine in United States Market
Table 2. Top Prophylactic Human Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Prophylactic Human Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Prophylactic Human Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Prophylactic Human Vaccine Sales by Companies, (K Units), 2016-2021
Table 6. United States Prophylactic Human Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Prophylactic Human Vaccine Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Prophylactic Human Vaccine Product Type
Table 9. List of Tier 1 Prophylactic Human Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Prophylactic Human Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Inactivated Vaccine
Table 12. Major Manufacturers of Attenuated Vaccine
Table 13. By Type - United States Prophylactic Human Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Prophylactic Human Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Prophylactic Human Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Prophylactic Human Vaccine Sales (K Units), 2016-2021
Table 17. By Type - United States Prophylactic Human Vaccine Sales (K Units), 2022-2027
Table 18. By Application - United States Prophylactic Human Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Prophylactic Human Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Prophylactic Human Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Prophylactic Human Vaccine Sales (K Units), 2016-2021
Table 22. By Application - United States Prophylactic Human Vaccine Sales (K Units), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. GSK Prophylactic Human Vaccine Product
Table 27. GSK Recent Developments
Table 28. Biovac Corporation Information
Table 29. Biovac Description and Major Businesses
Table 30. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Biovac Prophylactic Human Vaccine Product
Table 32. Biovac Recent Developments
Table 33. McKesson Medical Corporation Information
Table 34. McKesson Medical Description and Major Businesses
Table 35. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. McKesson Medical Prophylactic Human Vaccine Product
Table 37. McKesson Medical Recent Developments
Table 38. Merck Corporation Information
Table 39. Merck Description and Major Businesses
Table 40. Merck Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Merck Prophylactic Human Vaccine Product
Table 42. Merck Recent Developments
Table 43. Merial Corporation Information
Table 44. Merial Description and Major Businesses
Table 45. Merial Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Merial Prophylactic Human Vaccine Product
Table 47. Merial Recent Developments
Table 48. Zoetis Corporation Information
Table 49. Zoetis Description and Major Businesses
Table 50. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Zoetis Prophylactic Human Vaccine Product
Table 52. Zoetis Recent Developments
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Major Businesses
Table 55. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Sanofi Prophylactic Human Vaccine Product
Table 57. Sanofi Recent Developments
Table 58. Prophylactic Human Vaccine Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 59. United States Prophylactic Human Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Prophylactic Human Vaccine Market Opportunities & Trends in United States Market
Table 61. Prophylactic Human Vaccine Market Drivers in United States Market
Table 62. Prophylactic Human Vaccine Market Restraints in United States Market
Table 63. Prophylactic Human Vaccine Raw Materials
Table 64. Prophylactic Human Vaccine Raw Materials Suppliers in United States Market
Table 65. Typical Prophylactic Human Vaccine Downstream
Table 66. Prophylactic Human Vaccine Downstream Clients in United States Market
Table 67. Prophylactic Human Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Prophylactic Human Vaccine Product Picture
Figure 2. Prophylactic Human Vaccine Segment by Type
Figure 3. Prophylactic Human Vaccine Segment by Application
Figure 4. United States Prophylactic Human Vaccine Market Overview: 2020
Figure 5. United States Prophylactic Human Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Prophylactic Human Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Prophylactic Human Vaccine Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prophylactic Human Vaccine Revenue in 2020
Figure 9. Inactivated Vaccine Product Picture
Figure 10. Attenuated Vaccine Product Picture
Figure 11. Others Product Picture
Figure 12. By Type - United States Prophylactic Human Vaccine Sales Market Share, 2016-2027
Figure 13. By Type - United States Prophylactic Human Vaccine Revenue Market Share, 2016-2027
Figure 14. By Type - United States Prophylactic Human Vaccine Price (USD/Unit), 2016-2027
Figure 15. Hospital
Figure 16. Scientific Research
Figure 17. Others
Figure 18. By Application - United States Prophylactic Human Vaccine Sales Market Share, 2016-2027
Figure 19. By Application - United States Prophylactic Human Vaccine Revenue Market Share, 2016-2027
Figure 20. By Application - United States Prophylactic Human Vaccine Price (USD/Unit), 2016-2027
Figure 21. GSK Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Biovac Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. McKesson Medical Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Merck Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Merial Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Zoetis Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Sanofi Prophylactic Human Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. United States Prophylactic Human Vaccine Production Capacity (K Units), 2016-2027
Figure 29. Prophylactic Human Vaccine Industry Value Chain
Figure 30. Marketing Channels
  • Global and China Staphylococcal Infection Drugs Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 132
    Staphylococcal Infection Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Staphylococcal Infection Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on......
  • Global and China Equine Supplement Products Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 141
    Equine Supplement Products market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Equine Supplement Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Equ......
  • Global and China Postoperative Pain Therapeutics Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 147
    Postoperative Pain Therapeutics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Postoperative Pain Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses ......
  • Global and China Translational Regenerative Medicine Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 141
    Translational Regenerative Medicine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Translational Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report ......
  • Global and Japan Haemophilia Treatment Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 141
    Haemophilia Treatment market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Haemophilia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Haemophilia T......
  • Global and China Bispecific Antibodies for Cancer Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 135
    Bispecific Antibodies for Cancer market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bispecific Antibodies for Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuse......
  • Global and United States Embolization Microsphere Market Insights, Forecast to 2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 132
    Embolization Microsphere market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Embolization Microsphere market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the......
  • Global and Japan Antiretroviral Drug Market Size, Status and Forecast 2021-2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 97
    Global Antiretroviral Drug Scope and Market Size Antiretroviral Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiretroviral Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type......
  • Global and Japan Chemotherapy Drug Market Size, Status and Forecast 2021-2027
    Published: 25-Oct-2021        Price: US 3900 Onwards        Pages: 95
    Global Chemotherapy Drug Scope and Market Size Chemotherapy Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs